Medical Supplies and Services News

DETROIT, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...

New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Recently, MediGlow Utility (MGU) announced the release of its technical exploration framework focused on digital identity and privacy protection....

SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised...

Detroit, MI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...

Full-Year 2025 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI, Chief Financial...

Full-Year 2025 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI, Chief Financial...

Full-Year 2025 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI, Chief Financial...

CROSSJECT annonce l’initiation de couverture de son titre par Portzamparc (Groupe BNP Paribas) DIJON, France - 02 février 2026 (07h15CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), la...

CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJON, France - February 2, 2026 (7:15 a.m. CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the...

Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Key Highlights from the Quarter ACCENT Trial Success: The ACCENT trial, testing narmafotinib with gemcitabine and Abraxane®, continues to...